Expertise in
12
conditions
Expertise in
12
conditions
Blank Cancer & Blood Disorders Center
1215 Pleasant St Ste 514, 
Des Moines, IA 

Overview

Samantha Mallory is a Hematologist and an Oncologist in Des Moines, Iowa. Dr. Mallory is highly rated in 12 conditions, according to our data. Her top areas of expertise are Hepatoblastoma, Reticulohistiocytoma, Histiocytosis, Langerhans Cell Histiocytosis, and Bone Marrow Aspiration.

Her clinical research consists of co-authoring 3 peer reviewed articles and participating in 42 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Hematology
Oncology

Licenses

Pediatrics in OK

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellmark
  • HMO
  • POS
View 8 Less Insurance Carriers -

Locations

Blank Cancer & Blood Disorders Center
1215 Pleasant St Ste 514, Des Moines, IA 50309

Additional Areas of Focus

Dr. Mallory has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


42 Clinical Trials

Cancer Moonshot Biobank Research Protocol
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
A Phase 2 Randomized Study of Irinotecan/Temozolomide/Dinutuximab With or Without Eflornithine (DFMO) in Children With Relapsed, Refractory or Progressive Neuroblastoma
LEAHRN (Late Effects After High-Risk Neuroblastoma) Study
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
Computerized Cognitive Training for Pediatric Brain Tumor Patients: A Pilot Study
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
Renal Tumors Classification, Biology, and Banking Study
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND# 133688, NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A(MLL) Gene Rearrangement
View 41 Less Clinical Trials
Similar Doctors
Expertise in
98
conditions
Expertise in
98
conditions

Mission Cancer And Blood PLLC

1221 Pleasant St Ste 100, 
Des Moines, IA 
 (0.1 miles away)
Languages Spoken:
English

Robert Behrens is an Oncologist in Des Moines, Iowa. Dr. Behrens is highly rated in 98 conditions, according to our data. His top areas of expertise are Colorectal Cancer, Lung Cancer, Febrile Neutropenia, Bone Marrow Aspiration, and Colonoscopy.

Expertise in
8
conditions
Hematology | Oncology
Expertise in
8
conditions
Hematology | Oncology

Office

411 Laurel St, 
Des Moines, IA 
 (0.8 miles away)
Languages Spoken:
English

Roy Molina is a Hematologist and an Oncologist in Des Moines, Iowa. Dr. Molina is highly rated in 8 conditions, according to our data. His top areas of expertise are Multiple Myeloma, Lung Cancer, Pleuropulmonary Blastoma, Bone Marrow Aspiration, and Ureteroscopy.

Expertise in
25
conditions
Expertise in
25
conditions

Office

1221 Pleasant St Ste 400, 
Des Moines, IA 
 (0.1 miles away)
Languages Spoken:
English

Steven Elg is an Oncologist in Des Moines, Iowa. Dr. Elg is highly rated in 25 conditions, according to our data. His top areas of expertise are Endometrial Cancer, Endometrial Stromal Sarcoma, Malignant Mixed Mullerian Tumor, Ureteroscopy, and Bladder Reconstruction.

Frequently Asked Questions about Dr. Samantha Mallory

How do I make an appointment with Dr. Samantha Mallory?

You can book an appointment with Dr. Samantha Mallory by calling their office at 515-241-8912. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Samantha Mallory a top-rated expert for Hepatoblastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Samantha Mallory is classified as an Advanced expert for Hepatoblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Samantha Mallory specialize in?

While Dr. Samantha Mallory is a Hematology, they have specific expertise in Hepatoblastoma, Reticulohistiocytoma, and Histiocytosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Samantha Mallory participate in research or clinical trials?

Yes. Dr. Samantha Mallory has published 3 articles and abstracts on conditions like Hepatoblastoma. You can view a list of Dr. Samantha Mallory's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Samantha Mallory accept my insurance?

Dr. Samantha Mallory accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 515-241-8912 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mallory's expertise for a condition
ConditionClose
      View All 12 Advanced Conditions
      View All 8 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile